Merger · December 23, 2025
Deal stage
| Acquirer | FONAR, LLC |
| Target | FONAR Corporation |
| Deal type | Merger |
| Deal value | Undisclosed |
| Price Per Share | $19.00 |
| Premium | 29.6% |
| Financing | Cash |
| Announced | December 23, 2025 |
| Deal stage | Pending |
| Sector | Healthcare |
| Region | United States |
| Filing Type | DEFM14A |
Source
www.sec.gov →Last updated May 23, 2026 · Updated May 23, 2026
FONAR Corporation (Target)SEC filings →
| Revenue | $104.4M |
| Net Income | $8.3M |
| Total Assets | $216.9M |
FONAR, LLC (Acquirer)SEC filings →
| Revenue | $104.4M |
| Net Income | $8.3M |
| Total Assets | $216.9M |
Ask any question about this deal. Answers are grounded in live news and deal data.
CVC consortium / Recordati
May 22, 2026 · tender offer
Select Medical Holdings Corporation
Apr 28, 2026 · acquisition
Relativity Acquisition Corp. / Instinct Bio Technical Company Inc.
Mar 25, 2026 · merger
Merck / Terns Pharmaceuticals, Inc.
Mar 25, 2026 · acquisition